Glucotrack (GCTK) Asset Writedowns and Impairment (2013)

Glucotrack (GCTK) posted Asset Writedowns and Impairment of -$220132.0 for Q2 2013, down 136.02% on a QoQ basis from $611060.0 in Q1 2013.

Glucotrack (GCTK) Asset Writedowns and Impairment (2013) Analysis & Trends

Glucotrack's Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at -$220132.0 for Q2 2013.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to -$220132.0 in Q2 2013, while the trailing twelve-month figure through Sep 2016 was -$220132.0 (changed N/A YoY) and the FY2013 annual result came in at $390928.0, changed N/A from the prior year.
Asset Writedowns and Impairment was -$220132.0 for Q2 2013 at Glucotrack, down from $611060.0 in the prior quarter.
Across five years, Asset Writedowns and Impairment topped out at $611060.0 in Q1 2013 and bottomed at -$220132.0 in Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	124.80 Bn	119.58 Bn	1.96 Bn
2	Becton Dickinson	44.47 Bn	43.65 Bn	2.15 Bn
3	Alcon	33.17 Bn	31.51 Bn	1.53 Bn
4	Medline	32.67 Bn	30.44 Bn	1.84 Bn
5	Resmed	29.06 Bn	27.40 Bn	890.98 Mn
6	West Pharmaceutical Services	23.50 Bn	23.06 Bn	329.20 Mn
7	Solventum	13.91 Bn	13.35 Bn	1.10 Bn
8	Cooper Companies	13.82 Bn	13.68 Bn	735.40 Mn
9	Align Technology	12.13 Bn	11.07 Bn	736.59 Mn
10	Glucotrack	181,732.11	-7.20 Mn	-

Download Data